GNRH1 and ovarian hyperstimulation syndrome: The findings were close to another study [33] revealing that, in the patients with high ovarian response, the simultaneous administration of GnRH-a and hCG (1,000 to 2,500 IU) has been confirmed as an effective and safe trigger protocol, which achieved sustained pregnancy and reduced the risk of OHSS.